ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 214 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.96 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $1,350,000 | -61.3% | 41,611 | -66.7% | 0.35% | -47.6% |
| Q1 2016 | $3,490,000 | +375.5% | 124,853 | +505.6% | 0.67% | +546.6% |
| Q4 2015 | $734,000 | -85.3% | 20,615 | -86.6% | 0.10% | -76.9% |
| Q1 2015 | $5,009,000 | -42.1% | 153,717 | -43.6% | 0.44% | -42.5% |
| Q4 2014 | $8,647,000 | +8.9% | 272,350 | -15.1% | 0.77% | +5.2% |
| Q3 2014 | $7,943,000 | -16.4% | 320,821 | -23.7% | 0.74% | -4.4% |
| Q2 2014 | $9,497,000 | -7.9% | 420,411 | -0.9% | 0.77% | -2.5% |
| Q1 2014 | $10,316,000 | -51.1% | 424,032 | -49.8% | 0.79% | -44.8% |
| Q4 2013 | $21,087,000 | -16.6% | 843,851 | -8.3% | 1.43% | -12.6% |
| Q3 2013 | $25,272,000 | +47.4% | 920,017 | -2.6% | 1.64% | +19.8% |
| Q2 2013 | $17,150,000 | – | 944,930 | – | 1.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 25,819,768 | $972,631,000 | 7.89% |
| SECTORAL ASSET MANAGEMENT INC | 822,392 | $30,980,000 | 3.99% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 240,773 | $9,068,000 | 3.53% |
| HARVEY CAPITAL MANAGEMENT INC | 230,700 | $8,690,000 | 3.51% |
| Palo Alto Investors LP | 1,641,030 | $61,818,000 | 2.60% |
| GARRISON BRADFORD & ASSOCIATES INC | 73,350 | $2,763,000 | 2.31% |
| EMORY UNIVERSITY | 52,977 | $1,996,000 | 1.58% |
| Sivik Global Healthcare LLC | 120,000 | $4,520,000 | 1.54% |
| Stanley-Laman Group, Ltd. | 143,876 | $5,420,000 | 1.45% |
| ACUTA CAPITAL PARTNERS, LLC | 170,000 | $6,404,000 | 1.15% |